- •Contents
- •Contributors
- •1 Introduction
- •2.1 Posterior Compartment
- •2.2 Anterior Compartment
- •2.3 Middle Compartment
- •2.4 Perineal Body
- •3 Compartments
- •3.1 Posterior Compartment
- •3.1.1 Connective Tissue Structures
- •3.1.2 Muscles
- •3.1.3 Reinterpreted Anatomy and Clinical Relevance
- •3.2 Anterior Compartment
- •3.2.1 Connective Tissue Structures
- •3.2.2 Muscles
- •3.2.3 Reinterpreted Anatomy and Clinical Relevance
- •3.2.4 Important Vessels, Nerves, and Lymphatics of the Anterior Compartment
- •3.3 Middle Compartment
- •3.3.1 Connective Tissue Structures
- •3.3.2 Muscles
- •3.3.3 Reinterpreted Anatomy and Clinical Relevance
- •3.3.4 Important Vessels, Nerves, and Lymphatics of the Middle Compartment
- •4 Perineal Body
- •References
- •MR and CT Techniques
- •1 Introduction
- •2.1 Introduction
- •2.2.1 Spasmolytic Medication
- •2.3.2 Diffusion-Weighted Imaging
- •2.3.3 Dynamic Contrast Enhancement
- •3 CT Technique
- •3.1 Introduction
- •3.2 Technical Disadvantages
- •3.4 Oral and Rectal Contrast
- •References
- •Uterus: Normal Findings
- •1 Introduction
- •References
- •1 Clinical Background
- •1.1 Epidemiology
- •1.2 Clinical Presentation
- •1.3 Embryology
- •1.4 Pathology
- •2 Imaging
- •2.1 Technique
- •2.2.1 Class I Anomalies: Dysgenesis
- •2.2.2 Class II Anomalies: Unicornuate Uterus
- •2.2.3 Class III Anomalies: Uterus Didelphys
- •2.2.4 Class IV Anomalies: Bicornuate Uterus
- •2.2.5 Class V Anomalies: Septate Uterus
- •2.2.6 Class VI Anomalies: Arcuate Uterus
- •2.2.7 Class VII Anomalies
- •References
- •Benign Uterine Lesions
- •1 Background
- •1.1 Uterine Leiomyomas
- •1.1.1 Epidemiology
- •1.1.2 Pathogenesis
- •1.1.3 Histopathology
- •1.1.4 Clinical Presentation
- •1.1.5 Therapy
- •1.1.5.1 Indications
- •1.1.5.2 Medical Therapy and Ablation
- •1.1.5.3 Surgical Therapy
- •1.1.5.4 Uterine Artery Embolization (UAE)
- •1.1.5.5 Magnetic Resonance-Guided Focused Ultrasound
- •2 Adenomyosis of the Uterus
- •2.1 Epidemiology
- •2.2 Pathogenesis
- •2.3 Histopathology
- •2.4 Clinical Presentation
- •2.5 Therapy
- •3 Imaging
- •3.2 Magnetic Resonance Imaging
- •3.2.1 Magnetic Resonance Imaging: Technique
- •3.2.2 MR Appearance of Uterine Leiomyomas
- •3.2.3 Locations, Growth Patterns, and Imaging Characteristics
- •3.2.4 Histologic Subtypes and Forms of Degeneration
- •3.2.5 Differential Diagnosis
- •3.2.6 MR Appearance of Uterine Adenomyosis
- •3.2.7 Locations, Growth Patterns, and Imaging Characteristics
- •3.2.8 Differential Diagnosis
- •3.3 Computed Tomography
- •3.3.1 CT Technique
- •3.3.2 CT Appearance of Uterine Leiomyoma and Adenomyosis
- •3.3.3 Atypical Appearances on CT and Differential Diagnosis
- •4.1 Indications
- •4.2 Technique
- •Bibliography
- •Cervical Cancer
- •1 Background
- •1.1 Epidemiology
- •1.2 Pathogenesis
- •1.3 Screening
- •1.4 HPV Vaccination
- •1.5 Clinical Presentation
- •1.6 Histopathology
- •1.7 Staging
- •1.8 Growth Patterns
- •1.9 Treatment
- •1.9.1 Treatment of Microinvasive Cervical Cancer
- •1.9.2 Treatment of Grossly Invasive Cervical Carcinoma (FIGO IB-IVA)
- •1.9.3 Treatment of Recurrent Disease
- •1.9.4 Treatment of Cervical Cancer During Pregnancy
- •1.10 Prognosis
- •2 Imaging
- •2.1 Indications
- •2.1.1 Role of CT and MRI
- •2.2 Imaging Technique
- •2.2.2 Dynamic MRI
- •2.2.3 Coil Technique
- •2.2.4 Vaginal Opacification
- •2.3 Staging
- •2.3.1 General MR Appearance
- •2.3.2 Rare Histologic Types
- •2.3.3 Tumor Size
- •2.3.4 Local Staging
- •2.3.4.1 Stage IA
- •2.3.4.2 Stage IB
- •2.3.4.3 Stage IIA
- •2.3.4.4 Stage IIB
- •2.3.4.5 Stage IIIA
- •2.3.4.6 Stage IIIB
- •2.3.4.7 Stage IVA
- •2.3.4.8 Stage IVB
- •2.3.5 Lymph Node Staging
- •2.3.6 Distant Metastases
- •2.4 Specific Diagnostic Queries
- •2.4.1 Preoperative Imaging
- •2.4.2 Imaging Before Radiotherapy
- •2.5 Follow-Up
- •2.5.1 Findings After Surgery
- •2.5.2 Findings After Chemotherapy
- •2.5.3 Findings After Radiotherapy
- •2.5.4 Recurrent Cervical Cancer
- •2.6.1 Ultrasound
- •2.7.1 Metastasis
- •2.7.2 Malignant Melanoma
- •2.7.3 Lymphoma
- •2.8 Benign Lesions of the Cervix
- •2.8.1 Nabothian Cyst
- •2.8.2 Leiomyoma
- •2.8.3 Polyps
- •2.8.4 Rare Benign Tumors
- •2.8.5 Cervicitis
- •2.8.6 Endometriosis
- •2.8.7 Ectopic Cervical Pregnancy
- •References
- •Endometrial Cancer
- •1.1 Epidemiology
- •1.2 Pathology and Risk Factors
- •1.3 Symptoms and Diagnosis
- •2 Endometrial Cancer Staging
- •2.1 MR Protocol for Staging Endometrial Carcinoma
- •2.2.1 Stage I Disease
- •2.2.2 Stage II Disease
- •2.2.3 Stage III Disease
- •2.2.4 Stage IV Disease
- •4 Therapeutic Approaches
- •4.1 Surgery
- •4.2 Adjuvant Treatment
- •4.3 Fertility-Sparing Treatment
- •5.1 Treatment of Recurrence
- •6 Prognosis
- •References
- •Uterine Sarcomas
- •1 Epidemiology
- •2 Pathology
- •2.1 Smooth Muscle Tumours
- •2.2 Endometrial Stromal Tumours
- •3 Clinical Background
- •4 Staging
- •5 Imaging
- •5.1 Leiomyosarcoma
- •5.2.3 Undifferentiated Uterine Sarcoma
- •5.3 Adenosarcoma
- •6 Prognosis and Treatment
- •References
- •1.1 Anatomical Relationships
- •1.4 Pelvic Fluid
- •2 Developmental Anomalies
- •2.1 Congenital Abnormalities
- •2.2 Ovarian Maldescent
- •3 Ovarian Transposition
- •References
- •1 Introduction
- •4 Benign Adnexal Lesions
- •4.1.1 Physiological Ovarian Cysts: Follicular and Corpus Luteum Cysts
- •4.1.1.1 Imaging Findings in Physiological Ovarian Cysts
- •4.1.1.2 Differential Diagnosis
- •4.1.2 Paraovarian Cysts
- •4.1.2.1 Imaging Findings
- •4.1.2.2 Differential Diagnosis
- •4.1.3 Peritoneal Inclusion Cysts
- •4.1.3.1 Imaging Findings
- •4.1.3.2 Differential Diagnosis
- •4.1.4 Theca Lutein Cysts
- •4.1.4.1 Imaging Findings
- •4.1.4.2 Differential Diagnosis
- •4.1.5 Polycystic Ovary Syndrome
- •4.1.5.1 Imaging Findings
- •4.1.5.2 Differential Diagnosis
- •4.2.1 Cystadenoma
- •4.2.1.1 Imaging Findings
- •4.2.1.2 Differential Diagnosis
- •4.2.2 Cystadenofibroma
- •4.2.2.1 Imaging Features
- •4.2.3 Mature Teratoma
- •4.2.3.1 Mature Cystic Teratoma
- •Imaging Findings
- •Differential Diagnosis
- •4.2.3.2 Monodermal Teratoma
- •Imaging Findings
- •4.2.4 Benign Sex Cord-Stromal Tumors
- •4.2.4.1 Fibroma and Thecoma
- •Imaging Findings
- •4.2.4.2 Sclerosing Stromal Tumor
- •Imaging Findings
- •4.2.5 Brenner Tumors
- •4.2.5.1 Imaging Findings
- •4.2.5.2 Differential Diagnosis
- •5 Functioning Ovarian Tumors
- •References
- •1 Introduction
- •2.1 Context
- •2.2.2 Indications According to Simple Rules
- •References
- •CT and MRI in Ovarian Carcinoma
- •1 Introduction
- •2.1 Familial or Hereditary Ovarian Cancers
- •3 Screening for Ovarian Cancer
- •5 Tumor Markers
- •6 Clinical Presentation
- •7 Imaging of Ovarian Cancer
- •7.1.2 Peritoneal Carcinomatosis
- •7.1.3 Ascites
- •7.3 Staging of Ovarian Cancer
- •7.3.1 Staging by CT and MRI
- •Imaging Findings According to Tumor Stages
- •Value of Imaging
- •7.3.2 Prediction of Resectability
- •7.4 Tumor Types
- •7.4.1 Epithelial Ovarian Cancer
- •High-Grade Serous Ovarian Cancer
- •Low-Grade Serous Ovarian Cancer
- •Mucinous Epithelial Ovarian Cancer
- •Endometrioid Ovarian Carcinomas
- •Clear Cell Carcinomas
- •Imaging Findings of Epithelial Ovarian Cancers
- •Differential Diagnosis
- •Borderline Tumors
- •Imaging Findings
- •Differential Diagnosis
- •Recurrent Ovarian Cancer
- •Imaging Findings
- •Differential Diagnosis
- •Value of Imaging
- •Malignant Germ Cell Tumors
- •Dysgerminomas
- •Imaging Findings
- •Differential Diagnosis
- •Immature Teratomas
- •Imaging Findings
- •Malignant Transformation in Benign Teratoma
- •Imaging Findings
- •Differential Diagnosis
- •Sex-Cord Stromal Tumors
- •Granulosa Cell Tumors
- •Imaging Findings
- •Sertoli-Leydig Cell Tumor
- •Imaging Findings
- •Ovarian Lymphoma
- •Imaging Findings
- •Differential Diagnosis
- •7.4.3 Ovarian Metastases
- •Imaging Findings
- •Differential Diagnosis
- •7.5 Fallopian Tube Cancer
- •7.5.1 Imaging Findings
- •Differential Diagnosis
- •References
- •Endometriosis
- •1 Introduction
- •2.1 Sonography
- •3 MR Imaging Findings
- •References
- •Vagina and Vulva
- •1 Introduction
- •3.1 CT Appearance
- •3.2 MRI Protocol
- •3.3 MRI Appearance
- •4.1 Imperforate Hymen
- •4.2 Congenital Vaginal Septa
- •4.3 Vaginal Agenesis
- •5.1 Vaginal Cysts
- •5.1.1 Gardner Duct Cyst (Mesonephric Cyst)
- •5.1.2 Bartholin Gland Cyst
- •5.2.1 Vaginal Infections
- •5.2.1.1 Vulvar Infections
- •5.2.1.2 Vulvar Thrombophlebitis
- •5.3 Vulvar Trauma
- •5.4 Vaginal Fistula
- •5.5 Post-Radiation Changes
- •5.6 Benign Tumors
- •6.1 Vaginal Malignancies
- •6.1.1 Primary Vaginal Carcinoma
- •6.1.1.1 MRI Findings
- •6.1.1.2 Lymph Node Drainage
- •6.1.1.3 Recurrence and Complications
- •6.1.2 Non-squamous Cell Carcinomas of the Vagina
- •6.1.2.1 Adenocarcinoma
- •6.1.2.2 Melanoma
- •6.1.2.3 Sarcomas
- •6.1.2.4 Lymphoma
- •6.2 Vulvar Malignancies
- •6.2.1 Vulvar Carcinoma
- •6.2.2 Melanoma
- •6.2.3 Lymphoma
- •6.2.4 Aggressive Angiomyxoma of the Vulva
- •7 Vaginal Cuff Disease
- •7.1 MRI Findings
- •8 Foreign Bodies
- •References
- •Imaging of Lymph Nodes
- •1 Background
- •3 Technique
- •3.1.1 Intravenous Unspecific Contrast Agents
- •3.1.2 Intravenous Tissue-Specific Contrast Agents
- •References
- •1 Introduction
- •2.1.1 Imaging Findings
- •2.1.2 Differential Diagnosis
- •2.1.3 Value of Imaging
- •2.2 Pelvic Inflammatory
- •2.2.1 Imaging Findings
- •2.3 Hydropyosalpinx
- •2.3.1 Imaging Findings
- •2.3.2 Differential Diagnosis
- •2.4 Tubo-ovarian Abscess
- •2.4.1 Imaging Findings
- •2.4.2 Differential Diagnosis
- •2.4.3 Value of Imaging
- •2.5 Ovarian Torsion
- •2.5.1 Imaging Findings
- •2.5.2 Differential Diagnosis
- •2.5.3 Diagnostic Value
- •2.6 Ectopic Pregnancy
- •2.6.1 Imaging Findings
- •2.6.2 Differential Diagnosis
- •2.6.3 Value of Imaging
- •3.1 Pelvic Congestion Syndrome
- •3.1.1 Imaging Findings
- •3.1.2 Differential Diagnosis
- •3.1.3 Value of Imaging
- •3.2 Ovarian Vein Thrombosis
- •3.2.1 Imaging Findings
- •3.2.2 Differential Diagnosis
- •3.2.3 Value of Imaging
- •3.3 Appendicitis
- •3.3.1 Imaging Findings
- •3.3.2 Value of Imaging
- •3.4 Diverticulitis
- •3.4.1 Imaging Findings
- •3.4.2 Differential Diagnosis
- •3.4.3 Value of Imaging
- •3.5 Epiploic Appendagitis
- •3.5.1 Imaging Findings
- •3.5.2 Differential Diagnosis
- •3.5.3 Value of Imaging
- •3.6 Crohn’s Disease
- •3.6.1 Imaging Findings
- •3.6.2 Differential Diagnosis
- •3.6.3 Value of Imaging
- •3.7 Rectus Sheath Hematoma
- •3.7.1 Imaging Findings
- •3.7.2 Differential Diagnosis
- •3.7.3 Value of Imaging
- •References
- •MRI of the Pelvic Floor
- •1 Introduction
- •2 Imaging Techniques
- •3.1 Indications
- •3.2 Patient Preparation
- •3.3 Patient Instruction
- •3.4 Patient Positioning
- •3.5 Organ Opacification
- •3.6 Sequence Protocols
- •4 MR Image Analysis
- •4.1 Bony Pelvis
- •5 Typical Findings
- •5.1 Anterior Compartment
- •5.2 Middle Compartment
- •5.3 Posterior Compartment
- •5.4 Levator Ani Muscle
- •References
- •Evaluation of Infertility
- •1 Introduction
- •2 Imaging Techniques
- •2.1 Hysterosalpingography
- •2.1.1 Cycle Considerations
- •2.1.2 Technical Considerations
- •2.1.3 Side Effects and Complications
- •2.1.5 Pathological Findings
- •2.1.6 Limitations of HSG
- •2.2.1 Cycle Considerations
- •2.2.2 Technical Considerations
- •2.2.2.1 Normal and Abnormal Anatomy
- •2.2.3 Accuracy
- •2.2.4 Side Effects and Complications
- •2.2.5 Limitations of Sono-HSG
- •2.3 Magnetic Resonance Imaging
- •2.3.1 Indications
- •2.3.2 Technical Considerations
- •2.3.3 Limitations
- •3 Ovulatory Dysfunction
- •4 Pituitary Adenoma
- •5 Polycystic Ovarian Syndrome
- •7 Uterine Disorders
- •7.1 Müllerian Duct Anomalies
- •7.1.1 Class I: Hypoplasia or Agenesis
- •7.1.2 Class II: Unicornuate
- •7.1.3 Class III: Didelphys
- •7.1.4 Class IV: Bicornuate
- •7.1.5 Class V: Septate
- •7.1.6 Class VI: Arcuate
- •7.1.7 Class VII: Diethylstilbestrol Related
- •7.2 Adenomyosis
- •7.3 Leiomyoma
- •7.4 Endometriosis
- •References
- •MR Pelvimetry
- •1 Clinical Background
- •1.3.1 Diagnosis
- •1.3.2.1 Cephalopelvic Disproportion
- •1.3.4 Inadequate Progression of Labor due to Inefficient Contraction (“the Powers”)
- •2.2 Palpation of the Pelvis
- •3 MR Pelvimetry
- •3.2 MR Imaging Protocol
- •3.3 Image Analysis
- •3.4 Reference Values for MR Pelvimetry
- •5 Indications for Pelvimetry
- •References
- •MR Imaging of the Placenta
- •2 Imaging of the Placenta
- •3 MRI Protocol
- •4 Normal Appearance
- •4.1 Placenta Variants
- •5 Placenta Adhesive Disorders
- •6 Placenta Abruption
- •7 Solid Placental Masses
- •9 Future Directions
- •References
- •Erratum to: Endometrial Cancer
480 |
|
|
G. Masselli |
|
|
||
Table 2 Signal intensities of intrauterine hematoma over time |
|
||
|
|
|
|
Stages |
T1-weighted MR imaging |
T2-weighted MR imaging |
Diffusion-weighted MR imaging |
Hyperacute |
Isoto hypointense |
Hyperintense |
Hyperto hypointense |
Acute |
Isoto hypointense |
Hypointense |
Hypointense |
|
|
|
|
Early subacute |
Hyperintense |
Hypointense |
Hypointense |
|
|
|
|
Late subacute |
Hyperintense |
Hyperintense |
Hyperintense |
Chronic |
Hypointense |
Hypointense |
Isoto hypointense |
oxyhemoglobin), acute (1–3 days, intracellular deoxyhemoglobin), early subacute (3–7 days, intracellular methemoglobin), late subacute (≥14 days, extracellular methemoglobin), and chronic (>4 weeks, intracellular hemosiderin and ferritin) (Table 2).
MR signs of acute or recent bleeding within a hematoma can indicate a potentially unstable abruption, whereas hematomas with late subacute bleeding are stable.
Areas of hemorrhage in asymptomatic women are felt to result from venous bleeding of a remote nature, and treatment would typically be expectant management. Evidence of prior hemorrhage is not an uncommon finding in pregnancy, and when identified, it should be described in detail including multidimensional measurements, location, and proximity to the umbilical cord insertion and cervix.
MRI is an extremely accurate exam to identify the origin of secondand third-trimester uterine bleeding with an excellent interobserver agreement. With respect to US, it grants new and additional data that can influence the clinical management of these patients (Masselli et al. 2011c). Obstetricians will use this information to determine proper clinical and sonographic follow-up intervals to assess for fetal growth, anemia, and stress.
7\ Solid Placental Masses
Solid placental masses are rare; chorioangiomas are the most common tumor of the placenta and are identified in up to 1% of all placentas evaluated histologically. In up to 1:3500 births, chorioangiomas come to clinical attention (Sakornbut et al. 2007). These masses are typically >5 cm in
size and can be associated with polyhydramnios, hydropic changes in the fetus, intrauterine growth restriction, and congestive heart failure of the fetus due to vascularity of the mass. Chorioangiomas are benign tumors that can show intratumoral hemorrhage. Differentiating a placental hematoma from a solid mass, such as a chorioangioma, can be accomplished using color Doppler during sonographic evaluation (Sinha and Kuruba 2008). However, masses that have undergone hemorrhagic infarction or thrombosis can have limited internal flow and remain difficult to diagnose (Zalel et al. 2002a, b). Chorioangiomas can be homogeneous and nearly isointense to placenta on T1and T2-weighted images (Kawamoto et al. 2000). They are typically round in shape and may protrude from the placental surface. A very subtle thin capsule may be identified on T2-weighted images which does not mimic the regular septae of the placenta (Fig. 11). Peripheral areas of internal hemorrhage, manifesting as T1-shortening, have been described in case reports (Sakornbut et al. 2007; Oyelese and Ananth 2006). Similarly, in those masses with internal infarction or hemorrhage, increased T2-signal and increasing heterogeneity of the signal intensity have been reported. It is important to report the presence of prominent vessels along the fetal surface of the mass given potential for hemodynamic impact on the fetus. If there are early signs concerning for hydrops in the fetus, prompt notification of the ordering provider is indicated.
Similar to teratomas in other tissues, placental teratomas can contain virtually any tissue type including fat, calcification, fluid, and hair. Although teratomas in the placenta are extremely rare, in case reports, pregnancy outcomes are typically good (Elsasser et al. 2010). Although fat and calcification can be readily identified
MR Imaging of the Placenta |
481 |
|
|
|
|
a |
nal habitus. Acquisitions utilizing fat saturation |
|
for bulk fat, and opposed phase imaging to iden- |
||
|
||
|
tify intravoxel fat, may be helpful in the diagno- |
|
|
sis teratoma. Identification of fetal parts would |
|
|
suggest an anomalous additional gestation and |
|
|
may be more readily visible within the mass on |
|
|
T2-weighted and balanced steady-state free-pre- |
|
|
cession imaging. Identification of an umbilical |
|
|
cord (absent in teratoma) can also aid in differen- |
|
|
tiation (Elsasser et al. 2010). |
b
Fig. 11 Coronal (a) and axial (b) T2-weighted half-Fou- rier RARE images shows a well-circumscribed mass (arrows) arising from the fetal part of the placenta immediately adjacent to the insertion of the umbilical cord. This is the classic location for a chorioangioma
sonographically, differentiation from an anomalous additional gestation or fetus acardius amorphous can be difficult, and MRI may be requested if the diagnosis is uncertain. With a large field of view, the entire contents of the uterus can be readily evaluated in a single acquisition which is helpful in the setting of multiple gestations, excessive fetal movement, or unfavorable mater-
8\ MR Functional Imaging
of the Placenta
Despite the fact that MR imaging helps delineate the morphologic alterations of the placenta with appropriate conspicuity during gestation and is of use in the study of placental invasion (as in placenta percreta), few studies have addressed the functional properties of the human placental vasculature.
Magnetic resonance imaging requested for a potentially serious indication provided a unique opportunity to explore the intervillous circulation of placentas from pregnancies complicated by intrauterine growth restriction (IUGR) and to compare them to normal cases. This allowed an innovative characterization of in vivo utero-pla- cental blood flow, correlating a compromised intervillous circulation in IUGR to the deterioration of fetal condition (Moore et al. 2000).
MR images disclosed a homogeneous perfusion overall the placenta in normal cases, while IUGR placentas displayed a low intervillous blood flow, along with many patchy unperfused areas. Intermittent stops worsen the perfusion dynamics of the intervillous mostly in IUGR cases with an elevated ductus venosus pulsatility index. In IUGR placenta maternal placental blood flow is extremely compromised and that superimposed dynamic phenomena concur to worsen the intervillous circulation leading to an end-stage fetal decompensation (Brunelli et al. 2010).
However, MR evaluation of placental perfusion is limited by the inability to administer gadolinium due to concerns for fetal safety, and other forms of evaluation of placental
482 |
G. Masselli |
|
|
perfusion, including magnetization transfer, have been described.
This method takes advantage of the ratio of bound protons to total number of protons as a reflection of vascular flow. Owing to the clinical limitations of gadolinium-enhanced perfusion imaging, diffusion-weighted imaging is an alternative technique for studying regional ischemia caused by an insufficient vascular supply.
Among the many causes of diffusion restriction in human pregnancy, hematoma and infarctions are most important because they lead to dysmaturity of the placenta, resulting in smaller diffusive conductance and restricted blood supply owing to tissue degeneration and scarring (Brunelli et al. 2010).
9\ Future Directions
Cell-free fetal DNA is now used frequently in the United States as a screening test for aneuploidy. With the growth of this technology, several investigators have looked at using cell-free placental mRNA in maternal plasma to better identify patients with accreta requiring hysterectomy and also as a tool to combine with ultrasound to improve accuracy (Nyberg et al. 1987; Verswijvel et al. 2002). In the patient with risk factors for placental invasion, the combination of a laboratory serum test with ultrasound and/or MRI might yield the most consistent results.
Fusion of ultrasound images on MR volumes has been feasible for fetal antenatal evaluation in a study conducted by Salomon et al. (Masselli et al. 2011c). Utilizing high-resolution ultrasound images with the capability of real-time color Doppler can help determine vascularity of structures, especially as gadolinium-based contrast agents are not routinely used in the setting of pregnancy. This capability may be of particular interest in placental evaluation. Fetal MRI does not currently have a significant role in the evaluation of Twin-to-twin transfusion syndrome (TTTS); however, there are case reports of using MR-guided high-intensity-focused ultrasound (MR-HIFU) for ablation of the abnormal vessels in TTTS (Sebire et al. 2002).
As elsewhere in the body, functional MR techniques are being applied in the placenta in effort
to better evaluate normal physiology as well as pathologic states. The use of diffusion-weighted imaging has demonstrated restricted diffusion and reduced ADC values in the placentas of fetuses with growth restriction caused by placental insufficiency (Masselli et al. 2016). Diffusionweighted imaging has also been proposed for the evaluation of placental invasion. As gadoliniumbased contrast agents are not routinely used in pregnancy, noncontrast flow-sensitive methods, such as arterial spin labeling (ASL), have been proposed to assess placental perfusion (Masselli and Gualdi 2013).
In conclusion, MRI is an excellent modality in the evaluation of the placenta, and knowledge of the MR finding of various placental pathologies aids radiologists in the appropriate and timely care of the pregnant patients.
References
Baergren RN (2005) Placental shape aberrations. In: Baergren RN (ed) Manual of Benirschke and Kaufmann’s Pathology of the human placenta. Springer, New York, pp 208–221
Bardo D, Oto A (2008) Magnetic resonance imaging for evaluation of the fetus and the placenta. Am J Perinatol 25:591–599
Baughman WC, Corteville JE, Shah RR (2008) Placenta accreta: spectrum of US and MR imaging findings. Radiographics 28(7):1905–1916
Bernirschke K, Kaufmann P (2000) Pathology of the human placenta, 4th edn. Springer, New York
Bonel HM, Stolz B, Diedrichsen L, Frei K, Saar B, Tutschek B, Raio L, Surbek D, Srivastav S, Nelle M, Slotboom J, Wiest R (2010) Diffusion-weighted MR imaging of the placenta in fetuses with placental insufficiency. Radiology 257(3):810–819
Brunelli R, Masselli G, Parasassi T et al (2010) Intervillous circulation in intra-uterine growth restriction. Correlation to fetal well being. Placenta 31: 1051–1056
Derwig IE, Akolekar R, Zelaya FO, Gowland PA, Barker GJ, Nicolaides KH (2011) Association of placental volume measured by MRI and birth weight percentile. J Magn Reson Imaging 34(5):1125–1130
Dwyer BK, Belogolovkin V, Tran L et al (2008) Prenatal diagnosis of placenta accreta: sonography or magnetic resonance imaging? J Ultrasound Med 27: 1275–1281
Elsasser DA, Ananth CV, Prasad V, Vintzileos AM, Vintzileos AM (2010) Diagnosis of placental abruption: relationship between clinical and histopathologi-
MR Imaging of the Placenta |
483 |
|
|
cal findings. Eur J Obstet Gynecol Reprod Biol 148: 125–130
Elsayes KM, Trout AT, Friedkin AM, Liu PS, Bude RO, Platt JF, Menias C (2009) Imaging of the placenta: a multimodality pictorial review. Radiographics 29(5):1371–1391 Huppertz B (2008) The anatomy of the normal placenta.
J Clin Pathol 61:1296–1302
Kawamoto S, Ogawa F, Tanaka J, Ban S, Heshiki A (2000) Chorioangioma: antenatal diagnosis with fast MR imaging. Magn Reson Imaging 18(7):911–914
Kim JA, Narra VR (2004) Magnetic resonance imaging with true fast imaging with steady-state precession and half-Fourier acquisition single-shot turbo spinecho sequences in cases of suspected placenta accreta. Acta Radiol 45:692–698
Lam G, Kuller J, McMahon M (2002) Use of magnetic resonance imaging and ultrasound in the antenatal diagnosis of placenta accreta. J Soc Gynecol Investig 9:37–40
Lax A, Prince MR, Mennitt KW, Schwebach JR, Budorick NE (2007) The value of specific MRI features in the evaluation of suspected placental invasion. Magn Reson Imaging 25:87–93
Levine D (2006) Obstetric MRI. J Magn Reson Imaging 24:1–15
Levine D, Pedrosa I (2005) MR imaging of the maternal abdomen and pelvis in pregnancy. In: Levine D (ed) Atlas of fetal MRI. Taylor and Francis Group, Boca Raton, pp 202–210
Levine D, Hulka CA, Ludmir J, Li W, Edelman RR (1997) Placenta accreta: evaluation with color Doppler US, power Doppler US, and MR imaging. Radiology 205:773–776
Leyendecker JR, DuBose M, Hosseinzadeh K, Stone R, Gianini J, Childs DD, Snow AN, Mertz H (2012) MRI of pregnancy-related issues: abnormal placentation. AJR Am J Roentgenol 198(2):311–320
Linduska N, Dekan S, Messerschmidt A, Kasprian G, Brugger PC, Chalubinski K, Weber M, Prayer D (2009) Placental pathologies in fetal MRI with pathohistological correlation. Placenta 30(6):555–559
Masselli G, Gualdi G (2013) MR imaging of the placenta: what a radiologist should know. Abdom Imaging 38(3):573–587
Masselli G, Brunelli R, Casciani E et al (2008) Magnetic resonance imaging in the evaluation of placental adhesive disorders: correlation with color Doppler ultrasound. Eur Radiol 18:1292–1299
Masselli G, Brunelli R, Casciani E, Polettini E, Bertini L, Laghi F, Anceschi M, Gualdi G (2011a) Acute abdominal and pelvic pain in pregnancy: MR imaging as a valuable adjunct to ultrasound? Abdom Imaging 36(5):596–603
Masselli G, Brunelli R, Di Tola M et al (2011b) MR imaging in the evaluation of placental abruption: correlation with sonographic findings. Radiology 259:222–230
Masselli G, Brunelli R, Parasassi T, Perrone G, Gualdi G (2011c) Magnetic resonance imaging of clinically stable late pregnancy bleeding: beyond ultrasound. Eur Radiol 21(9):1841–1849
Masselli G, Perrone G, Kinkel K et al (2016) Are Second Trimester Apparent Diffusion Coefficient Values of the Short Uterine Cervix Associated with Impending Preterm Delivery? Radiology 280(3):897–904
Moore RJ, Strachan BK, Tyler DJ et al (2000) In utero perfusing fraction maps in normal and growth restricted pregnancy measured using IVIM echo-pla- nar MRI. Placenta 21:726–732
Morita S, Ueno E, Fujimura M, Muraoka M, Takagi K, Fujibayashi M (2009) Feasibility of diffusionweighted MRI for defining placental invasion. J Magn Reson Imaging 30:666–671
Nagayama M, Watanabe Y, Okumura A, Amoh Y, Nakashita S, Dodo Y (2002) Fast MR imaging in obstetrics. Radiographics 22:563–582
Nguyen D, Nguyen C, Yacobozzi M, Bsat F, Rakita D (2012) Imaging of the placenta with pathologic correlation. Semin Ultrasound CT MR 33:65–77
Nyberg DA, Mack LA, Benedetti TJ, Cyr DL, Schuman WP (1987) Placental abruption and placental hemorrhage: correlation of sonographic findings with fetal outcome. Radiology 164:357–361
Oyelese Y, Ananth CV (2006) Placental abruption. Obstet Gynecol 108:1005–1016
Oyelese Y, Smulian JC (2006) Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol 107:927–941 Palacios Jaraquemada JM, Bruno C (2000) Gadolinium enhanced MR imaging in the differential diagnosis of placenta accreta and placenta percreta. Radiology
216:610–611
Palacios Jaraquemada JM, Bruno CH (2005) Magnetic resonance imaging in 300 cases of placenta accreta: surgical correlation of new findings. Acta Obstet Gynecol Scand 84:716–724
Sakornbut E, Leeman L, Fontaine P (2007) Late pregnancy bleeding. Am Fam Physician 75:1199–2006 Sebire NJ, Sepulveda W (2008) Correlation of placental
pathology with prenatal ultrasound findings. J Clin Pathol 61:1276–1284
Sebire NJ, Foskett M, Fisher RA, Rees H, Seckl M, Newlands E (2002) Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age. BJOG 109(1):99–102
Sinha P, Kuruba N (2008) Ante-partum haemorrhage: an update. J Obstet Gynaecol 28:377–381
Tanaka YO, Sohda S, Shigemitsu S, Niitsu M, Itai Y (2001) High temporal resolution dynamic contrast MRI in a high risk group for placenta accreta. Magn Reson Imaging 19:635–642
To WW, Leung WC (1995) Placenta previa and previous cesarean section. Int J Gynaecol Obstet 51(1):25–31 Verswijvel G, Grieten M, Gyselaers W, Van Holsbeke C,
Vandevenne J, Horvath M, Gelin G, Palmers Y (2002) MRI in the assessment of pregnancy related intrauterine bleeding: a valuable adjunct to ultrasound? JBRBTR 85:189–192
Victoria T, Johnson AM, Kramer SS, Coleman B, Bebbington M, Epelman M (2011) Extrafetal findings at fetal MR: evaluation of the normal placenta and correlation with ultrasound. Clin Imaging 35:371–377
484 |
G. Masselli |
|
|
Warshak CR, Eskander R, Hull AD, Scioscia AL, Mattrey RF, Bernirschke K, Resnik R (2006) Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol 108:573–581
Zalel Y, Gamzu R, Weiss Y et al (2002a) Role of color Doppler imaging in diagnosing and managing preg-
nancies complicated by placental chorioangioma. J Clin Ultrasound 30(5):264–269
Zalel Y, Weisz B, Gamzu R, Schiff E, Shalmon B, Achiron R (2002b) Chorioangiomas of the placenta: sonographic and Doppler flow characteristics. J Ultrasound Med 21(8):909–913